LB11. A Single Dose of the MVA-BN Smallpox Vaccine Induces an Early Protective Antibody Response Similar to a Traditional Replicating Vaccine and Is Suitable for Emergency Scenario...

por Maclennan, Jane, Weidenthaler, Heinz, Pittman, Phillip, Schmidt, Darja, Chaplin, Paul
Publicado 2019

LB1579. A single and a two-dose regimen of MVA-BN elicit similar memory responses to a boost vaccination two years after the initial regimen, indicating potential flexibility for a...

por Weidenthaler, Heinz, Lienert, Florian, Reichhardt, Daniela, Schmidt, Darja, Silbernagl, Günter, Meyer, Thomas, Chaplin, Paul
Publicado 2022

A randomized phase 3 trial to assess the immunogenicity and safety of 3 consecutively produced lots of freeze-dried MVA-BN® vaccine in healthy adults

por Turner Overton, Edgar, Schmidt, Darja, Vidojkovic, Sanja, Menius, Erika, Nopora, Katrin, Maclennan, Jane, Weidenthaler, Heinz
Publicado 2023

Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine

por Jordan, Elke, Kabir, Golam, Schultz, Stephanie, Silbernagl, Günter, Schmidt, Darja, Jenkins, Victoria A, Weidenthaler, Heinz, Stroukova, Daria, Martin, Barbara K, De Moerlooze, Laurence
Publicado 2023

One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines

por Ilchmann, Heiko, Samy, Nathaly, Reichhardt, Daniela, Schmidt, Darja, Powell, Jacqueline D, Meyer, Thomas P H, Silbernagl, Günter, Nichols, Rick, Weidenthaler, Heinz, De Moerlooze, Laurence, Chen, Liddy, Chaplin, Paul
Publicado 2022

Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial

por Overton, Edgar Turner, Lawrence, Steven J., Wagner, Eva, Nopora, Katrin, Rösch, Siegfried, Young, Philip, Schmidt, Darja, Kreusel, Christian, De Carli, Sonja, Meyer, Thomas P., Weidenthaler, Heinz, Samy, Nathaly, Chaplin, Paul
Publicado 2018

A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Derma...

por Greenberg, Richard N, Hurley, Yadira, Dinh, Dinh V., Mraz, Serena, Vera, Javier Gomez, von Bredow, Dorothea, von Krempelhuber, Alfred, Roesch, Siegfried, Virgin, Garth, Arndtz-Wiedemann, Nathaly, Meyer, Thomas Peter, Schmidt, Darja, Nichols, Richard, Young, Philip, Chaplin, Paul
Publicado 2015

Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed...

por Greenberg, Richard N, Hurley, Maria Yadira, Dinh, Dinh V., Mraz, Serena, Vera, Javier Gomez, von Bredow, Dorothea, von Krempelhuber, Alfred, Roesch, Siegfried, Virgin, Garth, Arndtz-Wiedemann, Nathaly, Meyer, Thomas Peter, Schmidt, Darja, Nichols, Richard, Young, Philip, Chaplin, Paul
Publicado 2015

A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old S...

por Greenberg, Richard N., Hay, Christine M., Stapleton, Jack T., Marbury, Thomas C., Wagner, Eva, Kreitmeir, Eva, Röesch, Siegfried, von Krempelhuber, Alfred, Young, Philip, Nichols, Richard, Meyer, Thomas P., Schmidt, Darja, Weigl, Josef, Virgin, Garth, Arndtz-Wiedemann, Nathaly, Chaplin, Paul
Publicado 2016